Loading…
14: DIAmond [clear filter]
Monday, June 28
 

10:00am EDT

#100 SL: DIA Global Annual Meeting - Opening DIAmond and Plenary Session
Component Type: Session
CE: ACPE 1.25 Knowledge UAN: 0286-0000-21-668-L04-P; CME 1.25; IACET 1.25; RN 1.25

We are excited to welcome you to the DIA 2021 Virtual Global Annual Meeting
Join us for the Global Annual Meeting Welcome Remarks, Keynote Address, and Opening DIAmond Session!

Keynote Address: Kenneth Frazier, JD, Chairman of the Board and Chief Executive Officer, Merck & Co.
For most of us, the novel coronavirus represents an unprecedented time in our lives. However, history is full of accounts of humans grappling with viral invaders, and the positive innovations and learnings that we derive from these circumstances. Ken Frazier, Chairman and CEO of Merck, reflects on the discoveries that were made during pandemics of the past and their durable effects on science and society. Mr. Frazier also discusses the adaptations and accelerations required to develop vaccines and therapeutics to address the current pandemic, and their implications for the future of drug development. The lasting transformations of the COVID-19 pandemic may yet to be fully characterized, but we know they will be documented in the history books.

Opening Plenary Panel: Combating Misinformation in Health and Health Care
The COVID-19 era has been characterized by a strong anti-science bias among large swaths of the public in many countries. This includes those who deny the existence of COVID; those who oppose vaccines based on spurious science, correlation that does not reflect causality, or an unsupported belief that vaccines are untrustworthy or harmful; those who believe that science comes from an elite that may not have the best interests of the general public at heart; and many others.

All of these beliefs pose significant challenges to public health efforts to contain the spread of COVID and encourage widespread vaccination. The problem is compounded by the tremendous amounts of misinformation that have been circulating since the beginning of the pandemic. This misinformation has been promulgated through many channels, particularly on social media. While reputable sources have made many attempts to remove or discredit such information, these efforts have been far from successful. People also continue to receive misinformation from family, friends, and public figures.
The panel will address the following high-level topics:
  • How does misinformation about health and health care spread? Why do people believe it?
  • What do we know about how to successfully help people identify and question misinformation?
  • Who is best positioned to counter misinformation about COVID, and what do we know about how to do so effectively?
  • Are there specific approaches to combating misinformation that can help address known disparities in health and health care, particularly those that are COVID-related?


Learning Objectives

Identify two ways in which misinformation about health and health care spread; Identify one way in which to counter misinformation about COVID-19 effectively; Describe how known disparities in health and health care relate to the spread of misinformation about COVID-19.

Chair

Barbara Lopez Kunz, MBA, MS, MSc

Speaker

Opening Remarks
Judith Ng-Cashin, MD

Honorary Co-Chair
Emer Cooke, MBA, MSc

Honorary Co-Chair
Janet Woodcock, MD

Honorary Co-Chair
Yasuhiro Fujiwara, MD, PhD

Introduction of Keynote Speaker
Michael Rosenblatt, MD

Keynote Speaker
Kenneth Frazier, JD

Moderator: Combating Misinformation in Health and Health Care
Susan C. Winckler, JD, RPh

Panelist
Briony Swire-Thompson

Panelist
Brian Southwell, PhD

Panelist
Melanie Carr

Panelist
Richardae Araojo, PharmD, MS



Speakers
avatar for Barbara Lopez Kunz

Barbara Lopez Kunz

Global Chief Executive, DIA, United States
Barbara Lopez Kunz serves as President and Global Chief Executive of DIA, driving thought leadership and innovation in therapeutic development to improve the health of people worldwide. She previously served as President of Health and Life Sciences at Battelle, one of the world’s... Read More →
avatar for Emer Cooke

Emer Cooke

Executive Director, Chair, ICMRA, The European Medicines Agency, Netherlands
Ms Cooke is Executive Director of the EMA and Chair of ICMRA. Starting her mandate as ED in June 2020 amid a public health crisis of unprecedented scale she announced “My number one priority will be to drive forward EMA’s response to the pandemic and the work already ongoing to... Read More →
avatar for Janet Woodcock

Janet Woodcock

Acting Commissioner, FDA, United States
Dr. Janet Woodcock began her long and distinguished FDA career in 1986. In 1994, Dr. Woodcock was named Director of the CDER, overseeing the center’s work that is the world’s gold standard for drug approval and safety. In that position, she has led many of the FDA’s groundbreaking... Read More →
avatar for Yasuhiro Fujiwara

Yasuhiro Fujiwara

Chief Executive, Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Dr. Yasuhiro Fujiwara was previously Director-General, Strategic Planning Bureau of the National Cancer Center, and the Deputy Director of the Hospital (Research), National Cancer Center Hospital. He is a medical oncologist, specializing in breast cancer. Before joining NCCH, he was... Read More →
avatar for Michael Rosenblatt

Michael Rosenblatt

Chief Medical Officer, Flagship Pioneering, United States
Michael Rosenblatt, MD, Chief Medical Officer of Flagship Pioneering, has advanced academic and biopharmaceutical research and development throughout his career. He was previously Chief Medical Officer for Merck, after serving as Dean of Tufts Medical School. Formerly, he was Ebert... Read More →
avatar for Kenneth Frazier

Kenneth Frazier

Chairman of the Board and Chief Executive Officer, Merck & Co., Inc., United States
Kenneth C. Frazier has served as the Chairman of the Board and Chief Executive Officer of Merck & Co., Inc. since 2011. Under Ken’s leadership, Merck is delivering innovative lifesaving medicines and vaccines as well as long-term and sustainable value to its multiple stakeholders... Read More →
avatar for Susan Winckler

Susan Winckler

Chief Executive Officer, Reagan-Udall Foundation, United States
Prior to accepting the post at the FDA’s Foundation in May of 2020, she served as President of Leavitt Partners Solutions. She advised corporate executives on policy and business matters. As CEO of the Food & Drug Law Institute, she provided attorneys, regulators, industry leaders... Read More →
avatar for Brian Southwell

Brian Southwell

Senior Director, Science in the Public Sphere, Center for Communication Science, RTI International, United States
Dr. Brian Southwell is Senior Director of the Science in the Public Sphere Program in the Center for Communication Science at RTI International. He also is Adjunct Professor and Duke-RTI Scholar with Duke University and a graduate faculty member at the University of North Carolina... Read More →
avatar for Briony Swire-Thompson

Briony Swire-Thompson

Senior Research Scientist, Lazer Lab, Northeastern University Network Science Institute, United States
Briony Swire-Thompson is a Senior Research Scientist in the Lazer Lab, and fellow at Harvard University’s Institute for Quantitative Social Science. Her research investigates what drives belief in inaccurate information, why certain individuals are predisposed to refrain from belief... Read More →
avatar for Melanie Carr

Melanie Carr

Head of Stakeholders and Communication Division, European Medicines Agency, Netherlands
Melanie Carr is Head of the Stakeholders and Communication Division and a member of the Executive Board at the European Medicines Agency (EMA). She joined EMA in 1996 and has held various roles in pharmacovigilance, the centralised procedure for marketing authorisation, orphan medicines... Read More →
avatar for Richardae Araojo

Richardae Araojo

Associate Commissioner for Minority Health, Director, Office of Minority Health, FDA, United States
RDML Richardae Araojo serves as the Associate Commissioner for Minority Health and Director of the Office of Minority Health and Health Equity at the U.S. Food and Drug Administration. In this role she provides leadership, oversight, and direction on minority health, health disparity... Read More →
avatar for Judith Ng-Cashin

Judith Ng-Cashin

Chief Medical Officer, Eagle Pharmaceuticals, United States
Judith Ng-Cashin, MD, is currently the Chief Medical Officer at Eagle Pharmaceuticals, leading R&D across the development pipeline and marketed products. Prior to this role, she served as CMO for AOBiome Therapeutics, leading end-to-end asset development strategy, medical governance... Read More →


Monday June 28, 2021 10:00am - 11:45am EDT
TBD Virtual Event Horsham, PA 19044
  00: Plenary, Session |   14: DIAmond, Session
 
  • Timezone
  • Filter By Date DIA 2021 Virtual Global Annual Meeting Jun 1 -Jul 1, 2021
    • June 2021
      SunMonTueWedThuFriSat
       12345
      6789101112
      13141516171819
      20212223242526
      27282930 
      July 2021
      SunMonTueWedThuFriSat
       123
      45678910
      11121314151617
      18192021222324
      25262728293031
  • Filter By Venue Virtual Meeting
  • Filter By Type
  • 00: Plenary
  • 01: ClinSafety-PV
  • 02: ClinTrials -ClinOps
  • 03: Data-Data Standards
  • 04: MedAffairs-SciComm
  • 05: Patient Engagement
  • 06: PreClin Dev-EarlyPhaseCR
  • 07: ProjMgt-StrategicPlanning
  • 08: RD Quality-Compliance
  • 09: Regulatory
  • 10: RegCMC-Product Quality
  • 11: Statistics
  • 12: Value-Access
  • 13: ProfDevelopment
  • 14: DIAmond
  • 15: Content Hubs
  • 16: Community Rounds
  • 17: Posters
  • 18: Networking Opportunities
  • 19: Short Courses
  • 20: Early Access Content
  • 21: InnovationTheaters
  • 22: Solution Circles
  • 23: Spotlight Symposia
  • 24: Lunch-and-Learn
  • Beginner
  • Featured Topics

Filter sessions
Apply filters to sessions.